113 related articles for article (PubMed ID: 35006769)
1. Pt-Fe
Klein S; Otto J; Harreiß C; Distel LVR; Leistner A; Neuhuber W; Spiecker E; Kryschi C
ACS Appl Bio Mater; 2021 Nov; 4(11):7879-7892. PubMed ID: 35006769
[TBL] [Abstract][Full Text] [Related]
2. X-ray Dose-Enhancing Impact of Functionalized Au-Fe
Klein S; Distel LVR; Neuhuber W
ACS Appl Bio Mater; 2021 Apr; 4(4):3113-3123. PubMed ID: 35014399
[TBL] [Abstract][Full Text] [Related]
3. Caffeic Acid, Quercetin and 5-Fluorocytidine-Functionalized Au-Fe
Klein S; Distel LVR; Neuhuber W; Kryschi C
Nanomaterials (Basel); 2021 Apr; 11(5):. PubMed ID: 33947086
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Role of Surface Charge in Cellular Uptake and X-ray-Induced ROS Enhancing of Au-Fe
Klein S; Stiegler LMS; Harreiss C; Distel LVR; Neuhuber W; Spiecker E; Hirsch A; Kryschi C
ACS Appl Bio Mater; 2018 Dec; 1(6):2002-2011. PubMed ID: 34996262
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional Au-Fe
Klein S; Smuda M; Harreiß C; Menter C; Distel LVR; Kryschi C
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39613-39623. PubMed ID: 31613607
[TBL] [Abstract][Full Text] [Related]
6. NOBF
Klein S; Harreiß C; Menter C; Hümmer J; Distel LVR; Meyer K; Hock R; Kryschi C
ACS Appl Mater Interfaces; 2018 May; 10(20):17071-17080. PubMed ID: 29738226
[TBL] [Abstract][Full Text] [Related]
7. Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model.
Nosrati H; Baghdadchi Y; Abbasi R; Barsbay M; Ghaffarlou M; Abhari F; Mohammadi A; Kavetskyy T; Bochani S; Rezaeejam H; Davaran S; Danafar H
J Mater Chem B; 2021 Jun; 9(22):4510-4522. PubMed ID: 34027529
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency.
Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B
J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells.
Stankevicins L; Almeida da Silva AP; Ventura Dos Passos F; Dos Santos Ferreira E; Menks Ribeiro MC; G David M; J Pires E; Ferreira-Machado SC; Vassetzky Y; de Almeida CE; de Moura Gallo CV
Radiat Oncol; 2013 Oct; 8():231. PubMed ID: 24094113
[TBL] [Abstract][Full Text] [Related]
10. Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer.
Nosrati H; Ghaffarlou M; Salehiabar M; Mousazadeh N; Abhari F; Barsbay M; Ertas YN; Rashidzadeh H; Mohammadi A; Nasehi L; Rezaeejam H; Davaran S; Ramazani A; Conde J; Danafar H
Biomater Adv; 2022 Sep; 140():213090. PubMed ID: 36027669
[TBL] [Abstract][Full Text] [Related]
11. The effect of SiO
Darfarin G; Salehi R; Alizadeh E; Nasiri Motlagh B; Akbarzadeh A; Farajollahi A
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):836-846. PubMed ID: 29741418
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.
Martinel Lamas DJ; Cortina JE; Ventura C; Sterle HA; Valli E; Balestrasse KB; Blanco H; Cremaschi GA; Rivera ES; Medina VA
Cancer Biol Ther; 2015; 16(1):137-48. PubMed ID: 25482934
[TBL] [Abstract][Full Text] [Related]
13. The secretome of non-tumorigenic mammary cells MCF-10A elicits DNA damage in MCF-7 and MDA-MB-231 breast cancer cells.
Vedoya GM; López Nigro MM; Martín GA
Toxicol In Vitro; 2021 Feb; 70():105018. PubMed ID: 33049311
[TBL] [Abstract][Full Text] [Related]
14. Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.
McLean LS; Watkins CN; Campbell P; Zylstra D; Rowland L; Amis LH; Scott L; Babb CE; Livingston WJ; Darwanto A; Davis WL; Senthil M; Sowers LC; Brantley E
Chem Res Toxicol; 2015 May; 28(5):855-71. PubMed ID: 25781201
[TBL] [Abstract][Full Text] [Related]
15. Interruptin C, a Radioprotective Agent, Derived from
Chumsuwan N; Khongkow P; Kaewsuwan S; Kanokwiroon K
Molecules; 2022 May; 27(10):. PubMed ID: 35630775
[TBL] [Abstract][Full Text] [Related]
16. Ionizing Radiation Increases the Activity of Exosomal Secretory Pathway in MCF-7 Human Breast Cancer Cells: A Possible Way to Communicate Resistance against Radiotherapy.
Jabbari N; Nawaz M; Rezaie J
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349735
[TBL] [Abstract][Full Text] [Related]
17. Exposure of Breast and Lung Cancer Cells to a Novel Estrone Analog Prior to Radiation Enhances Bcl-2-Mediated Cell Death.
Nolte EM; Joubert AM; Lakier R; van Rensburg A; Mercier AE
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249026
[TBL] [Abstract][Full Text] [Related]
18. Cordycepin sensitizes breast cancer cells toward irradiation through elevating ROS production involving Nrf2.
Dong J; Li Y; Xiao H; Luo D; Zhang S; Zhu C; Jiang M; Cui M; Lu L; Fan S
Toxicol Appl Pharmacol; 2019 Feb; 364():12-21. PubMed ID: 30529626
[TBL] [Abstract][Full Text] [Related]
19. 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms.
Salama S; Diaz-Arrastia C; Patel D; Botting S; Hatch S
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):231-9. PubMed ID: 21392897
[TBL] [Abstract][Full Text] [Related]
20. The Psychiatric Drug Lithium Increases DNA Damage and Decreases Cell Survival in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines Expos ed to Ionizing Radiation.
Rouhani M; Ramshini S; Omidi M
Curr Mol Pharmacol; 2019; 12(4):301-310. PubMed ID: 31677257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
